Table of Contents Global Bioengineered Protein Drugs Sales Market Report 2018 by Manufacturer, Region, Type and Application 1 Bioengineered Protein Drugs Market Overview 1.1 Product Overview and Scope of Bioengineered Protein Drugs 1.2 Classification of Bioengineered Protein Drugs by Product Category 1.2.1 Global Bioengineered Protein Drugs Market Size (Sales) Comparison by Type (2012-2023) 1.2.2 Global Bioengineered Protein Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Therapeutic Proteins 1.2.4 Monoclonal Antibodies 1.2.5 Vaccines 1.3 Global Bioengineered Protein Drugs Market by Application/End Users 1.3.1 Global Bioengineered Protein Drugs Sales (Volume) and Market Share Comparison by Application (2012-2023) 1.3.2 Diabetes and Hormonal Disorders 1.3.3 Genetic and Fertility Disorders 1.3.4 Cancers 1.3.5 Organ Transplants 1.3.6 Others 1.4 Global Bioengineered Protein Drugs Market by Region 1.4.1 Global Bioengineered Protein Drugs Market Size (Value) Comparison by Region (2012-2023) 1.4.2 North America Bioengineered Protein Drugs Status and Prospect (2012-2023) 1.4.3 Europe Bioengineered Protein Drugs Status and Prospect (2012-2023) 1.4.4 China Bioengineered Protein Drugs Status and Prospect (2012-2023) 1.4.5 Japan Bioengineered Protein Drugs Status and Prospect (2012-2023) 1.4.6 Southeast Asia Bioengineered Protein Drugs Status and Prospect (2012-2023) 1.4.7 India Bioengineered Protein Drugs Status and Prospect (2012-2023) 1.5 Global Market Size (Value and Volume) of Bioengineered Protein Drugs (2012-2023) 1.5.1 Global Bioengineered Protein Drugs Sales and Growth Rate (2012-2023) 1.5.2 Global Bioengineered Protein Drugs Revenue and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Bioengineered Protein Drugs 2.2 Raw Material Analysis of Bioengineered Protein Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Bioengineered Protein Drugs 2.4 Other Costs Analysis of Bioengineered Protein Drugs 2.5 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs 2.6 Manufacturing Process Analysis of Bioengineered Protein Drugs 2.7 Raw Materials Sources of Bioengineered Protein Drugs Major Manufacturers in 2017 2.8 Downstream Buyers 3 Global Bioengineered Protein Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott Laboratories 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Laboratories Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.5 Abbott Laboratories Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.2 F. Hoffmann-La Roche Ltd 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 F. Hoffmann-La Roche Ltd Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.5 F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.3 Amgen, Inc. 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Amgen, Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.5 Amgen, Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.4 Bayer AG 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Bayer AG Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.5 Bayer AG Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.5 Merck & Co., Inc. 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck & Co., Inc. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.5 Merck & Co., Inc. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.6 Dr. Reddy's Laboratories Ltd. 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Dr. Reddy's Laboratories Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.5 Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.7 Biocon Ltd. 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biocon Ltd. Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.5 Biocon Ltd. Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.8 Eli Lilly and Company 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Eli Lilly and Company Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.5 Eli Lilly and Company Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.9 Sanofi 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sanofi Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.5 Sanofi Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.10 GlaxoSmithKline plc 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Bioengineered Protein Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 GlaxoSmithKline plc Different Types of Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.5 GlaxoSmithKline plc Bioengineered Protein Drugs Volume in Different Applications and Its Application Share 3.11 Johnson & Johnson 3.12 JanssenNovartis AG 3.13 Panacea Biotec 3.14 ProBioGen AG 4 Global Bioengineered Protein Drugs Market Competition by Players 4.1 Global Bioengineered Protein Drugs Sales (K Units) and Market Share (%) of Key Players (2012-2017) 4.1.1 Global Bioengineered Protein Drugs Sales (K Units) and Market Share (%) of Key Players (2012-2017) 4.1.2 Global Bioengineered Protein Drugs Revenue (Million USD) and Share by Players (2012-2017) 4.2 Global Bioengineered Protein Drugs Sales and Revenue by Type 4.1.1 Global Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) 4.1.2 Global Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) by Type (2012-2017) 4.3 Global Bioengineered Protein Drugs Sales and Revenue by Regions 4.3.1 Global Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Regions (2012-2017) 4.3.2 Global Bioengineered Protein Drugs Revenue and Market Share (%) by Regions (2012-2017) 4.4 Global Bioengineered Protein Drugs Revenue and Market Share (%) by Regions (2012-2017) 5 North America Bioengineered Protein Drugs (Volume, Value and Sales Price) 5.1 North America Bioengineered Protein Drugs Sales and Value (2012-2017) 5.1.1 North America Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 5.1.2 North America Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 5.1.3 North America Bioengineered Protein Drugs Sales Price Trend (2012-2017) 5.2 North America Bioengineered Protein Drugs Sales Volume and Market Share by Players 5.3 North America Bioengineered Protein Drugs Sales Volume and Market Share by Type 5.4 North America Bioengineered Protein Drugs Sales Volume and Market Share by Application 6 Europe Bioengineered Protein Drugs (Volume, Value and Sales Price) 6.1 Europe Bioengineered Protein Drugs Sales and Value (2012-2017) 6.1.1 Europe Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 6.1.2 Europe Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Europe Bioengineered Protein Drugs Sales Price Trend (2012-2017) 6.2 Europe Bioengineered Protein Drugs Sales Volume and Market Share by Players 6.3 Europe Bioengineered Protein Drugs Sales Volume and Market Share by Type 6.4 Europe Bioengineered Protein Drugs Sales Volume and Market Share by Application 7 China Bioengineered Protein Drugs (Volume, Value and Sales Price) 7.1 China Bioengineered Protein Drugs Sales and Value (2012-2017) 7.1.1 China Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 7.1.2 China Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 7.1.3 China Bioengineered Protein Drugs Sales Price Trend (2012-2017) 7.2 China Bioengineered Protein Drugs Sales Volume and Market Share by Players 7.3 China Bioengineered Protein Drugs Sales Volume and Market Share by Type 7.4 China Bioengineered Protein Drugs Sales Volume and Market Share by Application 8 Japan Bioengineered Protein Drugs (Volume, Value and Sales Price) 8.1 Japan Bioengineered Protein Drugs Sales and Value (2012-2017) 8.1.1 Japan Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 8.1.2 Japan Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Japan Bioengineered Protein Drugs Sales Price Trend (2012-2017) 8.2 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Players 8.3 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Type 8.4 Japan Bioengineered Protein Drugs Sales Volume and Market Share by Application 9 Southeast Asia Bioengineered Protein Drugs (Volume, Value and Sales Price) 9.1 Southeast Asia Bioengineered Protein Drugs Sales and Value (2012-2017) 9.1.1 Southeast Asia Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 9.1.2 Southeast Asia Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Southeast Asia Bioengineered Protein Drugs Sales Price Trend (2012-2017) 9.2 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Players 9.3 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Type 9.4 Southeast Asia Bioengineered Protein Drugs Sales Volume and Market Share by Application 10 India Bioengineered Protein Drugs (Volume, Value and Sales Price) 10.1 India Bioengineered Protein Drugs Sales and Value (2012-2017) 10.1.1 India Bioengineered Protein Drugs Sales and Growth Rate (2012-2017) 10.1.2 India Bioengineered Protein Drugs Revenue and Growth Rate (2012-2017) 10.1.3 India Bioengineered Protein Drugs Sales Price Trend (2012-2017) 10.2 India Bioengineered Protein Drugs Sales Volume and Market Share by Players 10.3 India Bioengineered Protein Drugs Sales Volume and Market Share by Type 10.4 India Bioengineered Protein Drugs Sales Volume and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 Global Bioengineered Protein Drugs Market Forecast (2018-2023) 12.1 Global Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast (2018-2023) 12.1.1 Global Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast (2018-2023) 12.1.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 Global Bioengineered Protein Drugs Price and Trend Forecast (2018-2023) 12.2 Global Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 Global Bioengineered Protein Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2023) 12.2.2 Global Bioengineered Protein Drugs Revenue and Growth Rate Forecast by Regions (2018-2023) 12.2.3 North America Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Europe Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 China Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 Japan Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.7 Southeast Asia Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.8 India Bioengineered Protein Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.3 Global Bioengineered Protein Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2023) 12.3.1 Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) 12.3.3 Global Bioengineered Protein Drugs Price Forecast by Type (2018-2023) 12.4 Global Bioengineered Protein Drugs Sales Volume Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Bioengineered Protein Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Bioengineered Protein Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Bioengineered Protein Drugs Table Global Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Bioengineered Protein Drugs Sales Market Share (%) by Types in 2017 Figure Therapeutic Proteins Picture Figure Monoclonal Antibodies Picture Figure Vaccines Picture Table Global Bioengineered Protein Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Global Sales Market Share (%) of Bioengineered Protein Drugs by Applications in 2017 Figure Diabetes and Hormonal Disorders Picture Figure Genetic and Fertility Disorders Picture Figure Cancers Picture Table Global Market Bioengineered Protein Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure North America Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Global Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2023) Table Global Bioengineered Protein Drugs Sales (K Units) of Key Players (2012-2017) Table Global Bioengineered Protein Drugs Sales Share (%) by Players (2012-2017) Figure 2016 Global Bioengineered Protein Drugs Sales Share (%) by Players Figure 2017 Global Bioengineered Protein Drugs Sales Share (%) by Players Table Global Bioengineered Protein Drugs Revenue by Players (2012-2017) Table Global Bioengineered Protein Drugs Revenue Share (%) by Players (2012-2017) Figure 2016 Global Bioengineered Protein Drugs Revenue Share (%) by Players Figure 2017 Global Bioengineered Protein Drugs Revenue Share (%) by Players Table Global Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Global Bioengineered Protein Drugs Sales Share (%) by Type (2012-2017) Figure Sales Market Share (%) of Bioengineered Protein Drugs by Type (2012-2017) Figure Global Bioengineered Protein Drugs Sales Growth Rate by Type (2012-2017) Table Global Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) by Type (2012-2017) Table Global Bioengineered Protein Drugs Revenue Share (%) by Type (2012-2017) Figure Revenue Market Share (%) of Bioengineered Protein Drugs by Type (2012-2017) Figure Global Bioengineered Protein Drugs Revenue Growth Rate by Type (2012-2017) Table Global Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Regions (2012-2017) Table Global Bioengineered Protein Drugs Sales Share (%) by Regions (2012-2017) Figure Sales Market Share (%) of Bioengineered Protein Drugs by Regions (2012-2017) Figure Global Bioengineered Protein Drugs Sales Market Share (%) by Regions in 2017 Table Global Bioengineered Protein Drugs Revenue (Million USD) and Market Share (%) by Regions (2012-2017) Table Global Bioengineered Protein Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share (%) of Bioengineered Protein Drugs by Regions (2012-2017) Figure Global Bioengineered Protein Drugs Revenue Market Share (%) by Regions in 2017 Table Global Bioengineered Protein Drugs Sales (K Units) and Market Share (%) by Application (2012-2017) Table Global Bioengineered Protein Drugs Sales Share (%) by Application (2012-2017) Figure Sales Market Share (%) of Bioengineered Protein Drugs by Application (2012-2017) Figure Global Bioengineered Protein Drugs Sales Market Share (%) by Application (2012-2017) Figure North America Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure North America Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure North America Bioengineered Protein Drugs Price (USD/Unit) Trend (2012-2017) Table North America Bioengineered Protein Drugs Sales (K Units) by Players (2012-2017) Table North America Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure North America Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players in 2017 Table North America Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table North America Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure North America Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type in 2017 Table North America Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table North America Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure North America Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure China Bioengineered Protein Drugs Price (USD/Unit) Trend (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) by Players (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players in 2017 Table China Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type in 2017 Table China Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table China Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure China Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure Europe Bioengineered Protein Drugs Price (USD/Unit) Trend (2012-2017) Table Europe Bioengineered Protein Drugs Sales (K Units) by Players (2012-2017) Table Europe Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure Europe Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players in 2017 Table Europe Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Europe Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure Europe Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type in 2017 Table Europe Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Europe Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Europe Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure Japan Bioengineered Protein Drugs Price (USD/Unit) Trend (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) by Players (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players in 2017 Table Japan Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type in 2017 Table Japan Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Japan Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Japan Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure India Bioengineered Protein Drugs Price (USD/Unit) Trend (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) by Players (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure India Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players in 2017 Table India Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure India Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type in 2017 Table India Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table India Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure India Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Players (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Players in 2017 Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Type (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Type in 2017 Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) by Applications (2012-2017) Table Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) Market Share (%) by Applications in 2017 Table Abbott Laboratories Basic Information List Table Abbott Laboratories Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Abbott Laboratories Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table F. Hoffmann-La Roche Ltd Basic Information List Table F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Ltd Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Amgen, Inc. Basic Information List Table Amgen, Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Amgen, Inc. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Bayer AG Basic Information List Table Bayer AG Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Bayer AG Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Merck & Co., Inc. Basic Information List Table Merck & Co., Inc. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Merck & Co., Inc. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Dr. Reddy's Laboratories Ltd. Basic Information List Table Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Dr. Reddy's Laboratories Ltd. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Biocon Ltd. Basic Information List Table Biocon Ltd. Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Biocon Ltd. Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Eli Lilly and Company Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Sanofi Basic Information List Table Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure Sanofi Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure Sanofi Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table GlaxoSmithKline plc Basic Information List Table GlaxoSmithKline plc Bioengineered Protein Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline plc Bioengineered Protein Drugs Sales Global Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Bioengineered Protein Drugs Revenue Global Market Share (%) (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Bioengineered Protein Drugs Figure Manufacturing Process Analysis of Bioengineered Protein Drugs Figure Bioengineered Protein Drugs Industrial Chain Analysis Table Raw Materials Sources of Bioengineered Protein Drugs Major Players in 2017 Table Major Buyers of Bioengineered Protein Drugs Table Distributors/Traders List Figure Global Bioengineered Protein Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Global Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Global Bioengineered Protein Drugs Price (USD/Unit) and Trend Forecast (2018-2023) Table Global Bioengineered Protein Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Global Bioengineered Protein Drugs Sales (K Units) Market Share (%) Forecast by Regions (2018-2023) Figure Global Bioengineered Protein Drugs Sales (K Units) Market Share (%) Forecast by Regions in 2023 Table Global Bioengineered Protein Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Bioengineered Protein Drugs Revenue Market Share (%) Forecast by Regions (2018-2023) Figure Global Bioengineered Protein Drugs Revenue Market Share (%) Forecast by Regions in 2023 Figure North America Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Europe Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure China Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Japan Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Southeast Asia Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure India Bioengineered Protein Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Bioengineered Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Table Global Bioengineered Protein Drugs Sales Forecast by Type (2018-2023) Figure Global Bioengineered Protein Drugs Sales Market Share (%) Forecast by Type (2018-2023) Table Global Bioengineered Protein Drugs Revenue Forecast by Type (2018-2023) Figure Global Bioengineered Protein Drugs Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Bioengineered Protein Drugs Price Forecast by Type (2018-2023) Table Global Bioengineered Protein Drugs Sales Forecast by Application (2018-2023) Figure Global Bioengineered Protein Drugs Sales Market Share (%) Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott Laboratories F. Hoffmann-La Roche Ltd Amgen, Inc. Bayer AG Merck & Co., Inc. Dr. Reddy's Laboratories Ltd. Biocon Ltd. Eli Lilly and Company Sanofi GlaxoSmithKline plc Johnson & Johnson JanssenNovartis AG Panacea Biotec ProBioGen AG